Research ArticleORIGINAL RESEARCH
Open Access
Factors That Predict Biological Aggressiveness in Estrogen Receptor–Positive / Human Epidermal Growth Factor Receptor 2–Negative / Lymph Node–Negative Breast Cancer
Lauren E. Arthur, Ashley H. McMann, Lauren N. Slattery, George M. Fuhrman, Aimee M. Mackey, Amy E. Rivere and Ralph L. Corsetti
Ochsner Journal December 2020, 20 (4) 381-387; DOI: https://doi.org/10.31486/toj.20.0035
Lauren E. Arthur
1The University of Queensland Faculty of Medicine, Ochsner Clinical School, New Orleans, LA
MDAshley H. McMann
2Department of Surgery, Lieselotte Tansey Breast Center, Ochsner Clinic Foundation, New Orleans, LA
MDLauren N. Slattery
1The University of Queensland Faculty of Medicine, Ochsner Clinical School, New Orleans, LA
MDGeorge M. Fuhrman
2Department of Surgery, Lieselotte Tansey Breast Center, Ochsner Clinic Foundation, New Orleans, LA
MD, FACSAimee M. Mackey
2Department of Surgery, Lieselotte Tansey Breast Center, Ochsner Clinic Foundation, New Orleans, LA
MD, FACSAmy E. Rivere
2Department of Surgery, Lieselotte Tansey Breast Center, Ochsner Clinic Foundation, New Orleans, LA
MD, FACSRalph L. Corsetti
3Department of Surgery, Division of Surgical Oncology, Tulane University School of Medicine, Covington, LA
MD, FACSREFERENCES
- 1.↵Breast cancer facts and figures 2019-2020. American Cancer Society. 2019. Accessed November 23, 2020. www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020.pdf
- 2.↵
- Goldhirsch A,
- Glick JH,
- Gelber RD,
- Coates AS,
- Senn HJ
- 3.↵
- Simon R
- 4.↵
- 5.Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. Diagnostics Guidance [DG34]. National Institute for Health and Care Excellence. December 19, 2018. Accessed December 2, 2020. www.nice.org.uk/guidance/dg34/chapter/1-Recommendations
- 6.
- Goldhirsch A,
- Winer EP,
- Coates AS,
- et al.
- 7.
- Harris L,
- Fritsche H,
- Mennel R,
- et al.
- 8.↵
- Gradishar WJ,
- Anderson BO,
- Balassanian R,
- et al.
- 9.↵
- 10.↵
- 11.↵
- Silverstein MJ,
- Skinner KA,
- Lomis TJ
- 12.↵
- Bardou VJ,
- Arpino G,
- Elledge RM,
- Osborner CK,
- Clark GM
- 13.↵
- 14.↵
- Goldstein LJ,
- Gray R,
- Badve S,
- et al.
- 15.↵
- 16.↵
- Paik S,
- Shak S,
- Tang G,
- et al.
- 17.↵
- 18.↵
- 19.↵
- Paik S,
- Tang G,
- Shak S,
- et al.
- 20.↵
- 21.↵
- Levine MN,
- Julian JA,
- Bedard PL,
- et al.
- 22.↵
- Albain KS,
- Allred DC,
- Clark GM
- 23.↵
- Nixon AJ,
- Neuberg D,
- Hayes DF,
- et al.
- 24.↵
- 25.↵
- Arpino G,
- Weiss H,
- Lee AV,
- et al.
- 26.↵
In this issue
Factors That Predict Biological Aggressiveness in Estrogen Receptor–Positive / Human Epidermal Growth Factor Receptor 2–Negative / Lymph Node–Negative Breast Cancer
Lauren E. Arthur, Ashley H. McMann, Lauren N. Slattery, George M. Fuhrman, Aimee M. Mackey, Amy E. Rivere, Ralph L. Corsetti
Ochsner Journal Dec 2020, 20 (4) 381-387; DOI: 10.31486/toj.20.0035
Factors That Predict Biological Aggressiveness in Estrogen Receptor–Positive / Human Epidermal Growth Factor Receptor 2–Negative / Lymph Node–Negative Breast Cancer
Lauren E. Arthur, Ashley H. McMann, Lauren N. Slattery, George M. Fuhrman, Aimee M. Mackey, Amy E. Rivere, Ralph L. Corsetti
Ochsner Journal Dec 2020, 20 (4) 381-387; DOI: 10.31486/toj.20.0035
Jump to section
Cited By...
- No citing articles found.